Randomized phase III study of adjuvant versus progression-triggered treatment with gemcitabine (G) after radical cystectomy (RC) for locally advanced bladder cancer (LABC) in patients not suitable for cisplatin-based chemotherapy (CBC) (AUO-trial AB22/00)

被引：4

作者：

Lehmann, Jan

Kuehn, Michael

Fischer, Claus

Volkmer, Bjoern

von Rundstedt, Friedrich

Albers, Peter

Becht, Eduard

Bannowsky, Andreas

Hofmann, Rainer

Langbein, Sigrun

Retz, Margitta

Stoeckle, Michael

机构：

[1] Univ Saarland, Dept Urol, Homburg, Germany

[2] Johanniter Krankenhaus Genthin Stendal gGmbH, Stendal, Germany

[3] Klinikum Hohe Warte Bayreuth, Bayreuth, Germany

[4] Hosp Kassel, Kassel, Germany

[5] HELIOS Klinikum Wuppertal GmbH, Wuppertal, Germany

[6] Univ Dusseldorf, Dept Urol, Dusseldorf, Germany

[7] Krankenhaus NW Frankfurt, Frankfurt, Germany

[8] Klinikum Osnabrueck, Osnabruck, Germany

[9] Univ Hosp Marburg, Marburg, Germany

[10] Zaans Med Zentrum, Zaandam, Netherlands

[11] Tech Univ Munich, Rechts Isar Med Ctr, Dept Urol, D-80290 Munich, Germany

[12] Saarland Univ Hosp, Homburg, Germany

来源：

关键词：

D O I：

10.1200/jco.2013.31.6_suppl.250

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

250

引用

页数：1